Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 181

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Shaping of Natural Killer Cell Antitumor Activity by Ex Vivo Cultivation

Open access
Granzin, Markus, Wagner, Juliane, Köhl, Ulrike, Cerwenka, Adelheid, Huppert, Volker, Ullrich, Evelyn · 2017 · Frontiers in Immunology

Abstract

Natural killer (NK) cells are a promising tool for the use in adoptive immunotherapy, since they efficiently recognize and kill tumor cells. In this context, ex vivo cultivation is an attractive option to increase NK cells in numbers and to improve their anti-tumor potential prior to clinical applications. Consequently, various strategies to generate NK cells for adoptive immunotherapy have been developed. Here, we give an overview of different NK cell cultivation approaches and their impact on shaping the NK cell anti-tumor activity. So far, the cytokines interleukin (IL)-2, IL-12, IL-15, IL-18 and IL-21 are used to culture and expand NK cells. The selection of the respective cytokine combination is an important factor that directly affects NK cell maturation, proliferation, survival, distribution of NK cell subpopulations, activation and function in terms of cytokine production and cytotoxic potential. Importantly, cytokines can up-regulate the expression of certain activating receptors on NK cells, thereby increasing their responsiveness against tumor cells that express the corresponding ligands. Apart from using cytokines, co-cultivation with autologous accessory non-NK cells or addition of growth-inactivated feeder cells are approaches for NK cell cultivation with pronounced effects on NK cell activation and expansion. Furthermore, ex vivo cultivation was reported to prime NK cells for the killing of tumor cells that were previously resistant to NK cell attack. In general, NK cells become frequently dysfunctional in cancer patients, for instance by down-regulation of NK cell activating receptors, disabling them in their anti-tumor response. In such scenario, ex vivo cultivation can be helpful to arm NK cells with enhanced anti-tumor properties to overcome immunosuppression. In this review we summarize the current knowledge on NK cell modulation by different ex vivo cultivation strategies, focused on increasing NK cytotoxicity for clinical application in malignant diseases. Moreover, we critically discuss the technical and regulatory aspects and challenges underlying NK cell based therapeutic approaches in the clinics.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fimmu.2017.00458

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 181

Metadata

Authors
Granzin, M., Wagner, J., Köhl, U., Cerwenka, A., Huppert, V., & Ullrich, E.
Venue
Frontiers in Immunology
Published
2017-04-26
Volume
8
Pages
458-458
ISSN
1664-3224 (ISSN-L)
OpenAlex
W2607529759
Cited by
181
References
7
FWCI
7.54
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Shaping of Natural Killer Cell Antitumor Activity by Ex Vivo Cultivation. https://app.cochat.ai/papers/10.3389/fimmu.2017.00458
The paper
Granzin, M., Wagner, J., Köhl, U., Cerwenka, A., Huppert, V., & Ullrich, E. (2017). Shaping of Natural Killer Cell Antitumor Activity by Ex Vivo Cultivation. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2017.00458

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.